Nephropathy associated with the diffuse infiltrative lymphocytosis syndrome

Kidney International

Volumn 72, Issue 2, 2007, Pages 219-224

  Zafrani, L ^a   Coppo, P ^b   Dettwiler, S ^c   Molinier Frenkel, V ^d   Agbalika, F ^e   Guiard Schmid, J B ^c   Pialoux, G ^c   Xu Dubois, Y C ^a   Rondeau, E ^a   Hertig, A ^a,c  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c HÔPITAL TENON   (France)

^d HENRI MONDOR HOSPITAL   (France)

^e SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CREATININE; EFAVIRENZ; LOPINAVIR; METHYLPREDNISOLONE; PREDNISONE; RITONAVIR; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; BABINSKI REFLEX; BLOOD PRESSURE MEASUREMENT; CASE REPORT; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DIFFUSE INFILTRATIVE LYMPHOCYTOSIS SYNDROME; DRUG DOSE REDUCTION; DYSESTHESIA; GAIT DISORDER; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY FAILURE; LABORATORY TEST; LIMB DYSESTHESIA; LUNG TUBERCULOSIS; LYMPHOCYTOSIS; MALE; MALE TO FEMALE TRANSSEXUAL; MEDICAL EXAMINATION; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; QUADRIPLEGIA; SYSTOLIC BLOOD PRESSURE; TISSUE SECTION; VIRUS LOAD;

CD8-POSITIVE T-LYMPHOCYTES; DIAGNOSIS, DIFFERENTIAL; HIV INFECTIONS; HUMANS; KIDNEY DISEASES; LYMPHOCYTOSIS; MALE; MIDDLE AGED;

EID: 34447503338     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002207     Document Type: Article

References (20)

1. Theodorou I, Delfau-Larue MH, Bigorgne C et al. Cutaneous T-cell infiltrates: analysis of T-cell receptor gamma gene rearrangement by polymerase chain reaction and denaturing gradient gel electrophoresis. Blood 1995; 86: 305-310.
2. Kimura H, Morita M, Yabuta Y et al. Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J Clin Microbiol 1999; 37: 132-136.
3. Tao Q, Ambinder RF, Swinnen LJ. Epstein-Barr virus (EBV) variant with a 30-bp deletion at the carboxyl terminus (amino acids 346-355) of latent membrane protein-1 (LMP1) gene is able to transform cells and evade immune surveillance. Am J Pathol 1998; 152: 1398-1399.
4. Itescu S, Brancato LJ, Winchester R. A sicca syndrome in HIV infection: association with HLA-DR5 and CD8 lymphocytosis. Lancet 1989; 2: 466-468.
5. Itescu S. Diffuse infiltrative lymphocytosis syndrome in children and adults infected with HIV-1: a model of rheumatic illness caused by acquired viral infection. Am J Reprod Immunol 1992; 28: 247-250.
6. Itescu S, Brancato LJ, Buxbaum J et al. A diffuse infiltrative CD8 lymphocytosis syndrome in human immunodeficiency virus (HIV) infection: a host immune response associated with HLA-DR5. Ann Intern Med 1990; 112: 3-10.
7. Kazi S, Cohen PR, Williams F et al. The diffuse infiltrative lymphocytosis syndrome. Clinical and immunogenetic features in 35 patients. Aids 1996; 10: 385-391.
8. Lesprit P, Fornairon S, Michaut P et al. Renal involvement in the diffuse infiltrative CD8 lymphocytosis syndrome. Aids 1997; 11: 262-263.
9. + lymphocytosis syndrome in HIV-infected patients. AIDS Read 2002; 12: 408-413.
10. Moulignier A, Authier FJ, Baudrimont M et al. Peripheral neuropathy in human immunodeficiency virus-infected patients with the diffuse infiltrative lymphocytosis syndrome. Ann Neurol 1997; 41: 438-445.
11. Basu D, Williams FM, Ahn CW et al. Changing spectrum of the diffuse infiltrative lymphocytosis syndrome. Arthritis Rheum 2006; 55: 466-472.
12. Gupta SK, Eustace JA, Winston JA et al. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2005; 40: 1559-1585.
13. Rossert J. Drug-induced acute interstitial nephritis. Kidney Int 2001; 60: 804-817.
14. Spanou Z, Keller M, Britschgi M et al. Involvement of drug-specific T cells in acute drug-induced interstitial nephritis. J Am Soc Nephrol 2006; 17: 2919-2927.
15. Martinez-Maza O, Breen EC. B-cell activation and lymphoma in patients with HIV. Curr Opin Oncol 2002; 14: 528-532.
16. Ruco LP, Di Napoli A, Pilozzi E et al. Peripheral T cell lymphoma with cytotoxic phenotype: an emerging disease in HIV-infected patients? AIDS Res Hum Retroviruses 2004; 20: 129-133.
17. + lymphocytes in HIV infection. J Clin Pathol 2000; 53: 177-181.
18. Rivera H, Nikitakis NG, Castillo S et al. Histopathological analysis and demonstration of EBV and HIV p-24 antigen but not CMV expression in labial minor salivary glands of HIV patients affected by diffuse infiltrative lymphocytosis syndrome. J Oral Pathol Med 2003; 32: 431-437.
19. Panayiotakopoulos GD, Aroni K, Kyriaki D et al. Paucity of Sjogren-like syndrome in a cohort of HIV-1-positive patients in the HAART era. Part II. Rheumatology (Oxford) 2003; 42: 1164-1167.
20. Izzedine H, Wirden M, Launay-Vacher V. Viral load and HIV-associated nephropathy. N Engl J Med 2005; 353: 1072-1074.